Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-21

FDA Approved: GANCICLOVIR — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's original application for GANCICLOVIR SODIUM (ganciclovir), marking a generic approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GANCICLOVIR SODIUM (GANCICLOVIR SODIUM)

Snippet

ORIG AP for GANCICLOVIR (GANCICLOVIR SODIUM)